Qynapse Company
Qynapse leverages neuroimaging & AI to advance the accuracy and reliability of Central Nervous System diseases screening and monitoring.
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2015-01-01
Last Funding Date:
2021-06-24
Total Funding:
6600000
Technology:
Artificial Intelligence, Clinical Trials, Health Care, Information Technology, Machine Learning, Medical, Neuroscience, Software
Employee Number:
11-50
Acquisitions Number:
1
Estimated Revenue:
$1M to $10M
Investors Number:
1
Industry:
Analytical Algoritms